News

The gene therapy chief wanted to block fast-track drug approvals.
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.
A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.
Vinay Prasad, M.D., has left the FDA less than three months into the role as director of the Center for Biologics Evaluation ...
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Prasad's exit ends a tumultuous tenure during which he led a reworking of agency guidelines on COVID vaccines and his office ...
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...